XML 117 R51.htm IDEA: XBRL DOCUMENT v2.4.1.9
ACQUISITION OF ZACHARON PHARMACEUTICALS, INC. (Tables) (Zacharon Pharmaceuticals Inc)
12 Months Ended
Dec. 31, 2014
Zacharon Pharmaceuticals Inc
 
Business Acquisition [Line Items]  
Summary of Estimated Fair Values of Assets Acquired and Liabilities Assumed

The following table presents the final allocation of the purchase consideration for the Zacharon acquisition, including the contingent acquisition consideration payable, based on fair value. The final allocation includes an adjustment to goodwill and the deferred tax assets of approximately $0.7 million resulting from the finalization of Zacharon’s tax returns.

 

Cash and cash equivalents

 

$

560

 

Other current assets

 

 

216

 

Property, plant and equipment

 

 

398

 

Acquired deferred tax assets

 

 

2,625

 

Other assets

 

 

38

 

IPR&D

 

 

11,680

 

Total identifiable assets acquired

 

 

15,517

 

Accounts payable and accrued expenses

 

 

(1,182

)

Debt assumed

 

 

(1,313

)

Deferred tax liability

 

 

(4,217

)

Total liabilities assumed

 

 

(6,712

)

Net identifiable assets acquired

 

 

8,805

 

Goodwill

 

 

2,715

 

Net assets acquired

 

$

11,520